BCMA-targeted CAR-T cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BCMA-targeted CAR-T cells, covering 2021-12-09 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma [Phase 1]